Chimeric Antigen Receptor T Cell Therapy Targeting CD19-Positive Leukemia and Lymphoma in the Context of Stem Cell Transplantation-Reference-Cited by-同舟云学术

Chimeric Antigen Receptor T Cell Therapy Targeting CD19-Positive Leukemia and Lymphoma in the Context of Stem Cell Transplantation

Published:2016-10 Issue:10 Volume:27 Page:758-771
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Schubert Maria-Luisa¹,Hückelhoven Angela¹,Hoffmann Jean-Marc¹,Schmitt Anita¹,Wuchter Patrick¹,Sellner Leopold¹,Hofmann Susanne¹,Ho Anthony D.¹,Dreger Peter¹,Schmitt Michael¹

Affiliation:

1. Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/hum.2016.097

Reference67 articles.

1. Monitoring and Prevention of Relapse after Allogeneic Hematopoietic Cell Transplantation for Myeloid Malignancies

2. Relapse after Allogeneic Hematopoietic Cell Therapy

3. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia [see comments]

4. Graft-versus-leukemia effects of transplantation and donor lymphocytes

5. Graft-versus-host disease after donor leukocyte infusions: presentation and management

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The crosstalk between immune cells and tumor pyroptosis: advancing cancer immunotherapy strategies;Journal of Experimental & Clinical Cancer Research;2024-07-10

2. Gene Editing and Gene Therapies in Cancer Treatment;Research Anthology on Bioinformatics, Genomics, and Computational Biology;2023-12-29

3. CRISPR, CAR-T, and NK: Current applications and future perspectives;Genes & Diseases;2023-09

4. Chimeric antigen receptor engineered T-cell therapy for central nervous system lymphoma;Hematology and Oncology Discovery;2022-07-19

5. Biological causes of immunogenic cancer cell death (ICD) and anti-tumor therapy; Combination of Oncolytic virus-based immunotherapy and CAR T-cell therapy for ICD induction;Cancer Cell International;2022-04-29